Bioterrorism Beyond Borders: Global Governance Failure at the Intersection of Security, Science, and Ethics

In an age where a virus can cross borders faster than diplomacy, bioterrorism has emerged as one of the most silent yet dangerous threats to national and global security. This paper will illustrate why bioterrorism is not only a security issue but also a failure in global governance, preparedness, and ethics in managing scientific knowledge. Unlike other security issues, bioterrorism is situated where the realms of biology, geopolitics, and ethics converge, thereby rendering global frames inefficient in regulating bioterrorism. Despite its severe global consequences, bioterrorism remains under-discussed in mainstream security debates.                 

Nevertheless, owing to the COVID-19 pandemic, rapid developments in the field of synthetic biology, and the universal availability of dual-use technology, bioterrorism has assumed potentially high prominence due to its global ramifications. 

From a human security perspective, bioterrorism fundamentally challenges state-centric notions of security by prioritising individual vulnerability, societal resilience, and structural inequality over territorial defence. This framework reveals how biological threats disproportionately affect populations with weak healthcare systems and fragile governance, thereby transforming bioterrorism into a crisis of global justice rather than merely national defence.

Biowar and Traditional Concepts of Security

The conventional model of security is ill-suited to meet the challenge of bioterrorism. The reason is that conventional security models are state-based and responsive. However, bioterrorism can be decentralised, clandestine, and asymmetric. Moreover, response strategies are further clouded because there is no definitive attribution. The reason is that biological attacks are different from missile strikes or hacking. For instance, biological attacks can sometimes appear like natural events. This inability to attribute responsibility directly weakens international accountability mechanisms, reinforcing the failure of global governance

The weakness of current policies is manifested in the Biological Weapons Convention of 1972. The BWC prohibits the development of biological weapons, their production, and their storage. Nevertheless, it has a weak verification mechanism. The BWC does not possess an inspection mechanism, unlike the Chemical Weapons Convention. This makes it difficult to track both state and non-state violators. This institutional weakness shows that global governance relies more on trust than enforcement, which is dangerous in the context of bioterrorism. 

Although the Biological Weapons Convention has been ratified by over 180 states, it remains one of the few major arms control treaties without a formal verification or inspection regime. This legal asymmetry renders compliance largely voluntary, thereby creating permissive conditions for both covert state programs and non-state exploitation.

Unlike nuclear weapons, where deterrence rests on visibility and attribution, or cyber warfare, where forensic tracing enables partial accountability, biological attacks often mimic natural outbreaks. This ambiguity erodes deterrence, complicates retaliation, and renders traditional security doctrines ineffective.

Technological Advances and the Dual-Use Problem

There are many threats associated with bioterrorism, which have increased because of the rapid development of biotechnology. The scientific hurdles in the manipulation of pathogens have been brought down by the development of gene-editing tools such as CRISPR-Cas9. Dual-use research of concern (DURC) is one of the concerns, although it has tremendous potential in agriculture and medicine.

Again, debates about biosafety, gain-of-function research, and biological lab safety were fueled by the COVID-19 pandemic. Regardless of origin, the SARS-CoV-2 controversy exposed the absence of enforceable global norms governing laboratory transparency, pathogen research disclosure, and cross-border scientific accountability. The debate exposed serious gaps in transparency and global scientific oversight of any deliberate creation or release of this virus. The World Economic Forum warned that emerging pathogens with enhanced transmissibility or resistance to treatment might be developed using synthetic biology.

The heightened mammalian transmissibility of the H5N1 Avian Influenza virus has become the focus of research published for the general public’s awareness, which has alarmed the US National Science Advisory Board for Biosecurity in 2022. These studies highlight the ethics of security versus research openness despite being undertaken for readiness.

Case studies from history and very recent history

Case studies of evidence in the past and the present time include the following illustrations of the evolving nature of bioterrorism. The most memorable incident is the anthrax mailings in the United States in the year 2001 (Amerithrax, 2022). The number of people who died was five. The level of fear created was high when letters containing the spores of anthrax were distributed in government institutions and the news media (Amerithrax, 2022). It should be noted that the consequences happened despite the high level of technological development.

In recent years, ricin, a very toxic biological agent, has been mailed to political institutions in the US and Europe and has been used for attempted assassination acts in 2018 and 2020. It is evident that with little effort and by evading traditional security systems for detection, biological toxins can be very easily weaponised.

The prospective misuse of synthetic DNA is another emerging concern. As of 2023, scientists pointed out that with inadequate screening capabilities, DNA synthesis companies could potentially use their services to recreate eliminated or highly dangerous pathogens. Although companies have put forward screening processes voluntarily, the lack of binding international norms remains a significant gap. These cases demonstrate that bioterrorism does not require state capacity, only access, intent, and weak oversight.

Public Health Preparedness and Structural Inequality

Bioterrorism also exposes large gaps in public health preparedness around the world. In addition, a lack of lab infrastructure, emergency preparedness, and disease surveillance in low- and middle-income countries can be a reality. Not a single country can effectively respond to a severe biological challenge, according to the Global Health Security Index. 

The 2021 Global Health Security Index found that the average global preparedness score stood below 40 out of 100, with no country fully equipped to prevent, detect, or respond to a major biological emergency. This gap persisted despite unprecedented technological and financial resources, underscoring the structural not incidental nature of biological insecurity. Even in advanced countries, there were severe deficits in controlling COVID-19, including a deficiency of health infrastructure, a dysfunctional government, and politicised public health programs.

Outbreaks such as Ebola in West Africa, Nipah virus in South Asia, and Zika in Latin America illustrate how limited surveillance capacity and delayed response mechanisms can transform local biological events into international emergencies, reinforcing the asymmetric global impact of biological threats.

These are structural, as opposed to purely logistical, disparities. The potential for weaker healthcare systems to transmit a regional outbreak into a global crisis underlines the reach of bioterrorism as a generator of social injustices, developments, and governance. There is, therefore, a blurred line between security and healthcare policies as a result of the threat posed by biological weapons.

Misinformation, Panic, and Social Amplification of Biological Threats

Misinformation environments represent a distinct risk factor for bioterrorism. Rumours travel faster than diseases in today’s modern technology era. Conspiracy theories, incorrect remedies, and misleading information diffuse rapidly through social media platforms, which undermine people's trust in medical institutions and professionals. Misinformation about COVID-19, for instance, has resulted in social division, defiance of medical control and regulation efforts, and reluctance to get vaccinated.

Misinformation could be a major channel of harm rather than being a secondary consequence of a bioterrorism attack. Mass migration, hoarding, and violence could be examples of behaviours that could be triggered due to panic and could even hamper the governance structures. There may be no clear-cut difference between bioterrorism and psychological warfare when information disorder is being deliberately used to add impact to the biological attack by the adversaries.

Reconsidering Response Policies and Global Governance 

For example, regarding bioterrorism, a certain degree of cooperation that has been urged somewhat generally must evolve instead toward institution-building and normative standards. First of all, there has to be a verification process of inspections and transparency to enhance the Biological Weapons Convention. For example, normative prohibitions are no more than symbolic without an element of accountability. 

Secondly, obligatory ethics norms should replace voluntary regulation in biotechnology governance globally. The assessment of risk, regulation of licensability, and enforcement regarding high-risk biological research could be done by an international organisation responsible for overseeing dual-use biological research, like that of the International Atomic Energy Agency. 

Third, national security planning has to factor in its response to bioterrorism. Notably, for regions that lack strong health structures, investments in biosurveillance, alert systems, and rapid diagnosis techniques should rank at the very top. Importantly, however, all of these measures have to be within bodies that are not military in nature. 

Fourth, data from the public health domain has to be incorporated into intelligence-sharing systems. The time taken to respond to biological threats has repeatedly been hindered by the artificial line separating health and security entities. Improved detection and attribution capabilities would require establishing formal arrangements to coordinate on either a regional or an international level. Finally, it is essential that science be addressed from an ethical governance perspective. High-risk assessment guidelines for scientists and compliance reports must be made statutory for universities, science institutions, and for-profit biotech enterprises. 

Conclusion

The international system has faced a challenge that has been irreversible in nature owing to bioterrorism. This follows the aspect that biological agents cannot be fully contained, uninvented, or recalled after they are released. The most vulnerable are always hit hardest by their aftereffects, which persist through time, space, and generations. This challenge differs from traditional weapons owing to their weakening of governance, erosion of trust, and undermining of the moral foundations of scientific progress. To consider bioterrorism simply another problem of security would be misleading. COVID-19, which caused millions of deaths and trillions in economic losses, demonstrated that even unintentional biological events can reshape global order making deliberate misuse an existential governance challenge.

It could be termed a failure of public health, a failure of governance, and an ethical dilemma, all rolled into one. Readiness plans, technological solutions, and more would not be sufficient in tackling the problem of bioterrorism. What it requires, instead, is a questioning of how knowledge can be controlled, how cooperation can be institutionalised, or how accountability can be shared in a globalised world. Otherwise, bioterrorism would not merely be a sleeping threat but a statement of the challenge of the world's inefficacy in ensuring that the fallout from its scientific developments does not spread. Bioterrorism is ultimately a test of whether humanity can govern its own scientific power responsibly and whether global society can evolve institutions of restraint, accountability, and ethical governance at the same pace as its scientific ingenuity.